Med. praxi. 2014;11(6):275-277

Mild cognitive impairment and dementia syndrome - cognitive function testing

Mgr.Tomáš Nikolai1, PhDr.Hana Štěpánková, Ph.D.2, Mgr.Ondřej Bezdíček, Ph.D.1
1 Centrum klinických neurověd, Neurologická klinika 1.LF UK a VFN v Praze
2 Psychiatrické centrum Praha

Diagnosing mild cognitive impairment and dementia syndrome has been of increasing importance in recent years in association with

population ageing. When determining the degree of cognitive impairment regardless of its aetiology, the diagnostic criteria describing

the syndrome of mild cognitive impairment and the dementia syndrome are applicable. Screening methods still play a role in practical



diagnosis: They can be used to assess the patient's cognitive status with a certain degree of probability. This article aims at presenting

the principles of a clinical screening test for cognition and the utility of selected most widely spread screening methods in the Czech

Republic. It deals with the principles of cognitive testing interview and the issue of subjective cognitive complaints. The Mini-Mental

State Examination and Montreal Cognitive Assessment are considered to be the most commonly used and available screening methods

in the Czech Republic. Attention is also paid to the clinical use of the still widely used Clock Drawing Test and other short cognitive tests.

Keywords: mild cognitive impairment, dementia, diagnosis

Published: December 1, 2014  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Nikolai T, Štěpánková H, Bezdíček O. Mild cognitive impairment and dementia syndrome - cognitive function testing. Med. praxi. 2014;11(6):275-277.
Download citation

References

  1. Nikolai T, Bezdíček O, Vyhnálek M, et al. Mírná kognitivní porucha: diagnostická jednotka nebo stadium předcházející demenci? Ceskoslov Psychol 2012; 56: 374-390.
  2. Petersen RC, Smith GE, Waring SC, et al. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 1999; 56: 303-308. Go to original source... Go to PubMed...
  3. Albert MS, DeKosky ST, Dickson D, et al. The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 2011; 7: 270-279. Go to original source... Go to PubMed...
  4. Litvan I, Goldman JG, Tröster AI, et al. Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines. Mov Disord 2012; 27: 349-356. Go to original source... Go to PubMed...
  5. Diagnostic and statistical manual of mental disorders: DSM5. American Psychiatric Association 2013.
  6. McKhann GM, Knopman DS, Chertkow H, et al. The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 2011; 7: 263-269. Go to original source... Go to PubMed...
  7. Dubois B, Burn D, Goetz C, et al. Diagnostic procedures for Parkinson's disease dementia: recommendations from the movement disorder society task force. Mov Disord 2007; 22: 2314-2324. Go to original source... Go to PubMed...
  8. Reisberg B, Prichep L, Mosconi L, et al. The pre-mild cognitive impairment, subjective cognitive impairment stage of Alzheimer's disease. Alzheimers Dement 2008; 4: S98-S108. Go to original source... Go to PubMed...
  9. Amariglio RE, Townsend MK, Grodstein F, et al. Specific subjective memory complaints in older persons may indicate poor cognitive function. J Am Geriatr Soc 2011; 59: 1612-1617. Go to original source... Go to PubMed...
  10. Topinková E, Jirák R, Kožený J. Krátká neurokognitivní baterie pro screening demence v klinické praxi: sedmiminutový screeningový test. Neurol Praxi 2002; 6: 323-328.
  11. Hummelová-Fanfrdlová Z, Rektorová I, Sheardová K, et al. Česká adaptace Addenbrookského kognitivního testu. Ceskoslov Psychol 2009; 53: 376-388.
  12. Folstein MF, Folstein SE, McHugh PR. 'Mini-mental state'. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-198. Go to original source... Go to PubMed...
  13. Cacho J, Benito-Leon J, García-García R, et al. Does the combination of the MMSE and clock drawing test (mini-clock) improve the detection of mild Alzheimer's disease and mild cognitive impairment? J Alzheimers Dis 2010; 22: 889-896. Go to original source... Go to PubMed...
  14. Nasreddine ZS, Phillips NA, Bédirian V, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 2005; 53: 695-699. Go to original source... Go to PubMed...
  15. Kopeček M, Štěpánková H, Lukavský J, et al. Montrealský kognitivní test (MOCA) a MMSE - české normy. Psychiatrie 2013; 17: 54-55.
  16. Ehreke L, Luppa M, König HH, et al. Is the Clock Drawing Test a screening tool for the diagnosis of mild cognitive impairment? A systematic review. Int Psychogeriatr 2010; 22: 56-63. Go to original source... Go to PubMed...
  17. Ladeira RB, Diniz BS, Nunes PV, et al. Combining cognitive screening tests for the evaluation of mild cognitive impairment in the elderly. Clin S?o Paulo Braz 2009; 64: 967-973. Go to original source... Go to PubMed...
  18. Borson S, Scanlan JM, Chen P, et al. The Mini-Cog as a screen for dementia: validation in a population-based sample. J Am Geriatr Soc 2003; 51: 1451-1454. Go to original source... Go to PubMed...
  19. Cowppli-Bony P, Fabrigoule C, Letenneur L, et al. [Validity of the five-word screening test for Alzheimer's disease in a population based study]. Rev Neurol 2005; 161: 1205-1212. Go to original source... Go to PubMed...




Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.